The largest database of trusted experimental protocols

Anti bad

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Anti-Bad is a laboratory reagent designed to detect and quantify the presence of a specific biological target in a sample. It functions as a highly specific and sensitive tool for researchers and scientists working in the field of molecular biology and biotechnology.

Automatically generated - may contain errors

24 protocols using anti bad

1

Protein Expression Analysis in Glioblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
U87 and T98G cells were lysed in radioimmunoprecipitation assay buffer [150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 50 mM Tris, pH 8.0, 5.0 mM ethylenediaminetetraacetic acid, pH 8.0, 0.5 mM dithiothreitol and 1 mM phenylmethylsulfonyl fluoride]. Protein concentrations were determined using the bicinchoninic acid method (Thermo Scientific, Rockford, IL, USA). Protein lysates were separated by SDS-polyacrylamide gel electrophoresis and transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA) by electroblotting. Primary antibodies for immunodetection were anti-CEP55 (Santa Cruz), anti-GLUT1 (Santa Cruz), anti-p-AktS473 (Santa Cruz), anti-p-AktT308(Santa Cruz), anti-Akt (Santa Cruz), anti-p-mTOR (Santa Cruz), anti-mTOR (Santa Cruz), anti-BAD (Santa Cruz), anti-caspase-9 (Santa Cruz), anti-GSK3-β (Santa Cruz), anti-p27 (Abcam) and anti-GAPDH (Santa Cruz). Subsequent to being incubated with Horseradish peroxidase (HRP) conjugated anti-rabbit or anti-mouse secondary antibodies (1: 10000, Santa Cruz) for 1 h, the immune complexes were detected using the enhanced chemiluminescence method.
+ Open protocol
+ Expand
2

Molecular Mechanisms of Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-GAPDH, anti-phospho-JNK1/2, anti-β-actin, anti-caspase-3, anti-caspase-7, anti-caspase-9, anti-poly(ADP-ribose) polymerase (PARP), anti-Bax, anti-Bad, anti-Bcl-2, anti-cytochrome c, anti-Akt, and anti-COX IV antibodies were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). SP600125, Z-VAD-FMK, MitoTEMPO, surfactin, and urban PM (SRM 1648a) were purchased from Sigma (St. Louis, MO, USA). N-acetyl-L-cysteine (NAC) and diphenyleneiodonium chloride (DPI) were taken from Biomol (Plymouth Meeting, PA).
+ Open protocol
+ Expand
3

Western Blot Analysis of Apoptosis Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted from cell samples by using RIPA buffer (Beyotime). 50 μg of the extracted and the co-precipitated proteins were separated by 10 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a PVDF membrane (Millipore, Billerica, MA, USA). After blocking in 5% nonfat milk for 2 h at room temperature, the membranes were incubated with anti-p-Bad (1:200, Santa Cruz), anti-p-AKT (1:200, Santa Cruz), anti-PTEN (1:200, Santa Cruz), anti-Bad (1:200, Santa Cruz), anti-AKT (1:200, Santa Cruz), anti-Bcl-2 (1:200, Santa Cruz), anti-cytochrome c (1:200, Santa Cruz), anti-caspase-9 (1:200, Santa Cruz) and anti-caspase-3 (1:200, Santa Cruz). After incubation with primary antibodies, membranes were washed and incubated with a horseradish peroxidase-conjugated secondary antibody (Santa Cruz) for 2 h at room temperature. Proteins on the membrane were visualized by using an enhanced chemiluminescence detection kit (Pierce, Rockford, IL, USA). Glyceraldehyde-3-phosphate (GAPDH) was used as an internal control to ensure equal protein loading. Mitochondria/Cytosol Fraction Kit (BioVision, Milpitas, CA, USA) was used to separate the mitochondria fraction and cytosol fraction before detection of cytochrome c.
+ Open protocol
+ Expand
4

Apoptosis Pathway Antibody Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used include anti-Bid (Luo et al.12 (link)), anti-Bim (Santa Cruz, Biotechnology, Inc, Dallas, TX, USA, Sc-11425, Calbiochem, San Diego, CA, USA, #202000), anti-Puma (Santa Cruz, Sc-28226, Pro-Sci, Inc, Poway, CA, USA, 3041), anti-Bad (Santa Cruz, Sc-8044), anti-Noxa (Santa Cruz, Sc-56169 Novus Biologicals, Littleton, CO, USA, IMG-349A), anti-Bax (Santa Cruz, Sc-493), anti-Bak (Santa Cruz, Sc-832, Cell Signaling Technology, Danvers, MA, USA, #3814), anti-Bcl-2 (Santa Cruz, Sc-509), anti-Bcl-xL (Santa Cruz, Sc-8392), anti-Mcl-1 (Santa Cruz, Sc-819), anti-β-actin (Sigma-Aldrich, St. Louis, MO, USA, A5441), anti-PARP (Cell Signaling Technologies, #9524), anti-GFP (Santa Cruz, Sc-459), and anti-p53 (Santa Cruz, Sc-393). z-VAD(OMe)-FMK was purchased from MP Biomedicals (Santa Ana, CA, USA). Thapsigargin was purchased from Adipogen. Corp (San Diego, CA, USA) ABT-737 was purchased from Cayman Chemical (Ann Arbor, MI, USA). Human recombinant TRAIL was made as previously described.61 (link)
+ Open protocol
+ Expand
5

Immunoblotting of Inflammatory Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
SH-SY5Y cells and VM organotypic cultures were treated with a lysis buffer and protein concentrations were estimated by the Bio-Rad protein assay using bovine serum albumin as standard, as previously described [10 (link)]. Specific primary antibody anti-iNOS (BD Transduction 610329; 1/500), anti-COX2 (Cell Signaling #4842 1/500), anti-Bid (1/500; Santa Cruz Biotechnology), anti-Bad (1/500; Santa Cruz Biotechnology), anti-IκBα (Santa Cruz Biotechnology sc-371; 1/500), anti-NFκB p65 (Santa Cruz Biotechnology sc-372; 1/500), anti-Bcl2 (Santa Cruz Biotechnology sc-7382; 1/500) and anti-Bax (Santa Cruz Biotechnology sc-7480; 1/500) were mixed in 1× PBS, 5% w/v nonfat dried milk, 0.1% Tween-20 (PMT) and incubated at 4°C, overnight. Signals were detected as described above [11 (link)].
+ Open protocol
+ Expand
6

Apoptotic Pathway Regulation by Piceatannol and Gemcitabine

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with piceatannol and gemcitabine as single agents and as a combination and then harvested by centrifugation at 450 × g for 10 min at 4°C. Cells were washed with ice-cold PBS solution and scraped in lysis buffer. The lysates were centrifuged at 14,000 rpm for 30 min at 4°C, and the supernatant was collected. Equivalent amounts of protein were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF membranes. Appropriate primary antibodies to anti-Bad, anti-Bak, anti-Bid, anti-Bcl-2, anti-Bcl-xl purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA) and the antibodies against cytochrome c (Cyto-c) and GAPDH obtained from Cell Signaling Technology (Beverly, MA, USA) were used. Proteins were visualized with a HRP-conjugated goat anti-rabbit secondary antibody from Santa Cruz Biotechnology. Specific bands were detected using the enhanced chemiluminescence reagent (ECL; PerkinElmer Life Sciences, Inc., Waltham, MA, USA) on autoradiographic film.
+ Open protocol
+ Expand
7

Western Blot Analysis of Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western Blot analysis on CAL27 cell culture was performed as previously described [52 (link)]. The following primary antibodies were detected: anti-Bax (1:500; Santa Cruz Biotechnology, Dallas, TX, USA; sc-7480); anti-Bcl2 (1:500; Santa Cruz Biotechnology, Dallas, TX, USA; sc-7382), anti-p53 (1:500; Santa Cruz Biotechnology, Dallas, TX, USA; sc-126); anti-Bad (1:500, Santa Cruz Biotechnology, Dallas, TX, USA; sc), anti-caspase3 (1:500, Santa Cruz Biotechnology, Dallas, TX, USA; sc-56053), anti-vascular endothelial growth factor (VEGF) (1:500; Santa Cruz Biotechnology, Dallas, TX, USA; sc-7269); anti-endothelial nitric oxide synthase (eNOS) (1:500; Santa Cruz Bio-technology, Dallas, TX, USA; sc-376751); anti-transforming growth factor beta (TGFβ) (1:500, Santa Cruz Biotechnology, Dallas, TX, USA; sc-130348); anti-βactin for cytosolic fraction (1:500; Santa Cruz Biotechnology; Dallas, TX, USA. sc-8432) and anti-lamin A/C for nuclear fraction (1:500; Santa Cruz Biotechnology; Dallas, TX, USA, sc-376248). Signals are perceived with enhanced chemiluminescence (ECL) detection system mixture (Thermo Fisher, Waltham, MA, USA).
+ Open protocol
+ Expand
8

Immunoprecipitation of Phospho-Bad Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoprecipitation was performed to examine the interaction of phospho-Bad and 14-3-3 interaction and Bcl-2 family proteins interaction. Protein samples (200 μg) were precleared with protein A/G agarose beads (Santa Cruz Biotechnology) to eliminate nonspecific binding proteins. They were mixed with following antibodies: anti-14-3-3, anti-Bad, and anti-Bax antibody (Santa Cruz Biotechnology) and incubated for overnight at 4°C with mild shaking. Complexes were precipitated with protein A/G agarose beads for 2 h at 4°C, washed with radioimmunoprecipitation assay buffer (Sigma Aldrich) with PMSF, and centrifuged at 10,000 g for 1 min. Supernatants were removed and remnant were boiled with sample buffer. They were loaded on 10% sodium dodecyl sulfate polyacrylamide gel, electrophoresed, and transferred to PVDF membrane. Membrane were rinsed with TBST and reacted with following antibodies: anti-phospho-Bad (1:1,000, diluted with TBST, Cell Signaling Technology), anti-Bcl-2, and anti-Bcl-xL antibody (1:1,000, diluted with TBST, Santa Cruz Biotechnology). They were washed with TBST and continuously performed as above described method in Western blot analysis.
+ Open protocol
+ Expand
9

Quantifying Apoptotic Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bax, Bcl-2, Bad, and Bcl-xl protein expression was determined on nuclear proteins separated from neuronal nuclei by SDS–polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes using a wet trans-blotting system (Ravishankar et al., 2001 (link)), as well as on cytosolic (Halat, 1992 (link)) and mitochondrial proteins (Lasso Pirot et al., 2007 (link)). The membranes were incubated with polyclonal anti-Bax, anti-Bcl2, anti-Bad, or anti–Bcl-xl antibodies (Santa Cruz Biotechnology). Immunoreactivity was then detected by incubation with horseradish peroxidase–conjugated secondary antibody (Rockland Immunochemicals). Specific complexes were detected by enhanced chemiluminescence method using the ECL detection system (Amersham Pharmacia Biotech) and analyzed by imaging densitometry (GS-700 densitometer, Bio-Rad). The densitometric scanning data were expressed as autoradiographic values per immunoblot protein. Concomitant actin protein gels were run to demonstrate the consistent amounts of protein in each sample. Samples were run in duplicates. Proteins were expressed as absorbance/OD (OD × mm2).
+ Open protocol
+ Expand
10

Antibody Validation in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
N-acetylcysteine was obtained from Sigma-Aldrich (St. Louis, MO, USA, A9165). The antibodies were obtained as follows: anti-actin (Chemicon, Billerica, MA, USA, 1501); anti-AKT (Cell Signaling, Danvers, MA, USA, 9272); anti-Bad (Santa Cruz, Dallas, TX, USA, sc-7869); anti-Bax (Santa Cruz, sc-493); anti-Bcl-2 (Santa Cruz; sc-509); anti-Bcl-XL (Cell Signaling, 2764); anti-Bim (Cell Signaling, 2933); anti-Caspase 2 (Cell Signaling, 2224); anti-Caspase 3 (Imgenex, San Diego, CA, USA, IMG-144A); anti-cIAP1 (R&D Systems, Minneapolis, MN, USA, AF8181); anti-GAPDH (Santa Cruz, sc-32233); anti-ISCU (Santa Cruz; sc-373694); anti-Mcl-1 (Santa Cruz, sc-819); anti-pAKT (S472/473) (Cell Signaling, 4058); anti-Puma (Cell Signaling, 4976); anti-XIAP (Cell Signaling, 2045).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!